This report contains market size and forecasts of Human Coagulation Factor IV in global, including the following market information:
- Global Human Coagulation Factor IV Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Human Coagulation Factor IV Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Human Coagulation Factor IV companies in 2021 (%)
The global Human Coagulation Factor IV market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Calcium Ion Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Coagulation Factor IV include Baxter, Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, Novo Nordisk and Greencross, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Coagulation Factor IV manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Coagulation Factor IV Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Human Coagulation Factor IV Market Segment Percentages, by Type, 2021 (%)
- Calcium Ion
- Calcium Compounds
Global Human Coagulation Factor IV Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Human Coagulation Factor IV Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Personal Clinic
- Others
Global Human Coagulation Factor IV Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Human Coagulation Factor IV Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Human Coagulation Factor IV revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Human Coagulation Factor IV revenues share in global market, 2021 (%)
- Key companies Human Coagulation Factor IV sales in global market, 2017-2022 (Estimated), (K Pcs)
- Key companies Human Coagulation Factor IV sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Baxter
- Bayer
- CSL
- Pfizer
- Grifols
- Biogen
- Octapharma
- Novo Nordisk
- Greencross
- Kedrion
- BPL
- Hualan Bio
- RAAS
